U.S. & Canada Skin Cancer Dermatology Market Size, Share & Trends Analysis Report By Test Type (Skin Biopsy, Diagnostic Imaging), By Facility Type (Hospital OPDs, Stand-alone Practices), By Age Group, And Segment Forecasts, 2022 - 2030

Table of Contents

Chapter 1 Methodology and Scope
1.1 Segment Market Scope
1.2 Estimates and Forecast Timeline
1.3 Research Methodology
1.3.1 Information procurement
1.3.2 Purchased database:
1.3.3 GVR’s Internal Database
1.3.4 Secondary sources:
1.3.5 Primary Research:
1.4 List of Primary Sources
1.5 Information Or Data Analysis
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Approach 1: Bottom up Approach
1.8 Objectives
1.8.1 Objective 1:
1.8.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 U.S. Market Variable Analysis
3.2.1 Market driver analysis
3.2.1.1 Increase in the prevalence of skin cancer
3.2.1.2 Exposure to ultraviolet radiation
3.2.1.3 Constant technological advancements in skin cancer diagnostic tests
3.3 Canada Market Variable Analysis
3.3.1 Market driver analysis
3.3.1.1 Increasing incidence of melanoma in Canada
3.3.1.2 Technological advancements
3.3.1.3 Increasing awareness campaigns and supportive government initiatives
3.3.2 U.S. Market restraint analysis
3.3.2.1 Lack of universal health coverage
3.3.3 Canada Market restraint analysis
3.3.3.1 Shortage of medical resources and limited access to healthcare.
3.4 Penetration & Growth Prospect Mapping
3.4.1 U.S. Penetration & Growth Prospect Mapping, By Test Type
3.4.2 Canada Penetration & Growth Prospect Mapping, By Test Type
3.5 Business Environment Analysis tools
3.5.1 SWOT Analysis, by PEST
3.5.2 Porter’s five forces analysis
3.5.3 U.S. & Canada Dermatology Market: Competitive insight
3.5.3.1 Role of concierge medicine/boutique medicine in the dermatology space
3.5.3.2 Advantages of Concierge Medicine:
3.5.3.3 Disadvantages of Concierge Medicine:
3.5.3.4 Role of nurse practitioners and physician assistants in the value chain of skin cancer screening
3.5.3.5 Technological Advancements
3.5.3.6 Decision support systems & Dermatology software
3.5.3.7 Artificial intelligence in dermatology
3.5.3.8 Applications:
Chapter 4 U.S. Dermatology Market: Segment Analysis by Test Type
4.1 U.S. Dermatology Market: Test Type Movement Analysis
4.2 Skin Biopsy
4.2.1 Skin Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
4.3 Dermatoscopy
4.3.1 Dermatoscopy market estimates and forecasts, 2018 - 2030 (USD Million)
4.4 Diagnostic Imaging
4.4.1 Diagnostic imaging market estimates and forecasts, 2018 - 2030 (USD Million)
4.5 Lymph Node Biopsy
4.5.1 Lymph Node Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5 Canada Dermatology Market: Segment Analysis by Test Type
5.1 Canada Dermatology Market: Test Type Movement Analysis
5.2 Skin Biopsy
5.2.1 Skin Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
5.3 Dermatoscopy
5.3.1 Dermatoscopy market estimates and forecasts, 2018 - 2030 (USD Million)
5.4 Diagnostic Imaging
5.4.1 Diagnostic imaging market estimates and forecasts, 2018 - 2030 (USD Million)
5.5 Lymph Node Biopsy
5.5.1 Lymph Node Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6 U.S. Dermatology Market: Segment Analysis by Facility Type
6.1 U.S. Dermatology Market: Facility Type Movement Analysis
6.2 Standalone Practices
6.2.1 Standalone Practices market estimates and forecasts, 2018 - 2030 (USD Million)
6.3 Multispecialty Clinics
6.3.1 Multispecialty Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
6.4 Dermatology Groups
6.4.1 Dermatology Groups market estimates and forecasts, 2018 - 2030 (USD Million)
6.5 Hospital Outpatient Departments
6.5.1 Hospital Outpatient Departments market estimates and forecasts, 2018 - 2030 (USD Million)
6.6 Others (Integrated Delivery Network)
6.6.1 Others (Integrated Delivery Network) market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7 Canada Dermatology Market: Segment Analysis by Facility Type
7.1 Canada Dermatology Market: Facility Type Movement Analysis
7.2 Standalone Practices
7.2.1 Standalone Practices market estimates and forecasts, 2018 - 2030 (USD Million)
7.3 Multispecialty Clinics
7.3.1 Multispecialty Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
7.4 Dermatology Groups
7.4.1 Dermatology Groups market estimates and forecasts, 2018 - 2030 (USD Million)
7.5 Hospital Outpatient Departments
7.5.1 Hospital Outpatient Departments market estimates and forecasts, 2018 - 2030 (USD Million)
7.6 Others (Integrated Delivery Network)
7.6.1 Others (Integrated Delivery Network) market estimates and forecasts, 2018 - 2030 (USD Million)
第八章美国皮肤科市场:段Analysis by Age-group
8.1 U.S. Dermatology Market: Age-group Movement Analysis
8.2 0-19
8.2.1 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
8.2.2 Male 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
8.2.3 Female 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
8.3 20-39
8.3.1 20-39 Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2 Male 20-39 market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.3 Female 20-39 market estimates and forecasts, 2018 - 2030 (USD Million)
8.4 40-59
8.4.1 40-59 Market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.2 Male 40-59 market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.3 Female 40-59 market estimates and forecasts, 2018 - 2030 (USD Million)
8.5 60-64
8.5.1 60-64 Market estimates and forecasts, 2018 - 2030 (USD MILLION)
8.5.2 Male 60-64 market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.3 Female 60-64 market estimates and forecasts, 2018 - 2030 (USD Million)
8.6 65-74
8.6.1 65-74 Market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.2 Male 65-74 market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.3 Female 65-74 market estimates and forecasts, 2018 - 2030 (USD Million)
8.7 75-84
8.7.1 75-84 Market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.2 Male 75-84 market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.3 Female 75-84 market estimates and forecasts, 2018 - 2030 (USD Million)
8.8 85 & above
8.8.1 85 & above Market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.2 Male 85 & above market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.3 Female 85 & above market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 9 Canada Dermatology Market: Segment Analysis by Age-group
9.1 Canada Dermatology Market: Age-group Movement Analysis
9.2 0-19
9.2.1 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
9.2.2 Male 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
9.2.3 Female 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
9.3 20-39
9.3.1 20-39 Market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.2 Male 20-39 market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.3 Female 20-39 market estimates and forecasts, 2018 - 2030 (USD Million)
9.4 40-59
9.4.1 40-59 Market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.2 Male 40-59 market estimates and forecasts, 2018 - 2030 (USD Million)
9.4.3 Female 40-59 market estimates and forecasts, 2018 - 2030 (USD Million)
9.5 60-64
9.5.1 60-64 Market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.2 Male 60-64 market estimates and forecasts, 2018 - 2030 (USD Million)
9.5.3 Female 60-64 market estimates and forecasts, 2018 - 2030 (USD Million)
9.6 65-74
9.6.1 65-74 Market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.2 Male 65-74 market estimates and forecasts, 2018 - 2030 (USD Million)
9.6.3 Female 65-74 market estimates and forecasts, 2018 - 2030 (USD Million)
9.7 75-84
9.7.1 75-84 Market estimates and forecasts, 2018 - 2030 (USD Million)
9.7.2 Male 75-84 market estimates and forecasts, 2018 - 2030 (USD Million)
9.7.3 Female 75-84 market estimates and forecasts, 2018 - 2030 (USD Million)
9.8 85 & above
9.8.1 85 & above market estimates and forecasts, 2018 - 2030 (USD Million)
9.8.2 Male 85 & above market estimates and forecasts, 2018 - 2030 (USD Million)
9.8.3 Female 85 & above market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 10 Competitive Analysis
10.1 Company Profiles
10.1.1 Firefly
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product Benchmarking
10.1.2 SkinIO
10.1.2.1 Company overview
10.1.2.2 Financial performance
10.1.2.3 Product Benchmarking
10.1.2.4 Strategic Initiative
10.1.3 Canfield Scientific, Inc.
10.1.3.1公司概述
10.1.3.2 Financial performance
10.1.3.3 Product Benchmarking
10.1.3.4 Strategic Initiative
10.1.4 FotoFinder Systems, Inc.
10.1.4.1 Company overview
10.1.4.2财务业绩
10.1.4.3 Product Benchmarking
10.1.5 3GEN
10.1.5.1 Company overview
10.1.5.2 Financial performance
10.1.5.3 Product Benchmarking
10.1.6 MetaOptima
10.1.6.1 Company overview
10.1.6.2 Financial performance
10.1.6.3 Product Benchmarking
10.1.6.4 Strategic Initiative
10.1.7 Agilent Technologies
10.1.7.1 Company overview
10.1.7.2 Financial performance
10.1.7.3 Product Benchmarking
10.1.7.4 Strategic Initiative
10.1.8 SkinVision
10.1.8.1 Company overview
10.1.8.2 Financial performance
10.1.8.3 Product Benchmarking
10.1.9 Speclipse, INC.
10.1.9.1 Company overview
10.1.9.2 Financial performance
10.1.9.3 Product Benchmarking
10.1.10 Skin Analytics
10.1.10.1 Company overview
10.1.10.2 Financial performance
10.1.10.3 Product Benchmarking

List of Tables

Table 1 List of secondary sources
Table 2 U.S. ski cancer dermatology market, by facility type, 2018 - 2030 (USD Million)
Table 3 U.S. skin cancer dermatology market, by test type, 2018 - 2030 (USD Million)
Table 4 U.S. skin cancer dermatology market, by age group, 2018 - 2030 (USD Million)
Table 5 Canada skin cancer dermatology market, by facility type, 2018 - 2030 (USD Million)
Table 6 Canada skin cancer dermatology market, by test type, 2018 - 2030 (USD Million)
Table 7 Canada skin cancer dermatology market, by age group, 2018 - 2030 (USD Million)

List of Fig.ures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 U.S. Dermatology market snapshot (2021)
Fig. 8 Canada Dermatology market snapshot (2021)
Fig. 9 Dermatology market segmentation
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Penetration & growth prospect mapping, by test type
Fig. 15 Penetration & growth prospect mapping, by test type
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 Porter’s five forces analysis
Fig. 18 Dermatology market test type outlook: Key takeaways
Fig. 19 U.S. Dermatology market: Test type movement analysis
Fig. 20 Skin biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Dermatoscopy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Diagnostic imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Lymph node biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Dermatology market test type outlook: Key takeaways
Fig. 25 Canada Dermatology market: Test type movement analysis
Fig. 26 Skin biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Dermatoscopy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Diagnostic imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Lymph node biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Dermatology market facility type outlook: Key takeaways
Fig. 31 U.S. Dermatology market: facility type movement analysis
Fig. 32 Standalone practices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Multispecialty Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Dermatology Groups market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Hospital outpatient departments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Others (Integrated Delivery Network) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Dermatology market facility type outlook: Key takeaways
Fig. 38 Canada Dermatology market: facility type movement analysis
Fig. 39 Standalone practices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Multispecialty Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Dermatology Groups market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Hospital outpatient departments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Others (Integrated Delivery Network) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Dermatology market age-group outlook: Key takeaways
Fig. 45 U.S. Dermatology market: age-group movement analysis
Fig. 46 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Male 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Female 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 20-39 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Male 20-39 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Female 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 40-59 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Male 40-59 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Female 40-59 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 60-64 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Male 60-64 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Female 60-64 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58. 65-74 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Male 65-74 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Female 65-74 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 75-84 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Male 75-84 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Female 75-84 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 85 & above market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Male 85 & above market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Female 85 & above market estimates and forecasts, 2018 - 2030 (USD Million)
图67皮肤病market age-group outlook: Key takeaways
Fig. 68 Canada Dermatology market: age-group movement analysis
Fig. 69 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Male 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Female 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 20-39 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Male 20-39 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Female 0-19 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 40-59 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Male 40-59 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Female 40-59 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 60-64 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Male 60-64 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Female 60-64 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 65-74 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Male 65-74 market estimates and forecasts, 2018 - 2030 (USD Million)
图83女65 - 74市场估计和预测s, 2018 - 2030 (USD Million)
Fig. 84 75-84 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Male 75-84 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Female 75-84 market estimates and forecasts, 2018 - 2030 (USD Million)
图87 85 &高于市场估计和预测,2018 - 2030 (USD Million)
Fig. 88 Male 85 & above market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Female 85 & above market estimates and forecasts, 2018 - 2030 (USD Million)